abstract |
The present invention relates to the following general formula [I] (Wherein each symbol is as described in the specification), or a pharmaceutically acceptable salt thereof, and a hepatitis C virus (HCV) polymerase containing the compound The present invention relates to an inhibitor and a therapeutic agent for hepatitis C. The compound of the present invention exhibits anti-HCV action by inhibiting HCV polymerase and is useful as a therapeutic or prophylactic agent for hepatitis C. |